Western Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
13,214
+4,665
+55% +$4.73M 0.46% 39
2025
Q4
$9.19M Buy
8,549
+88
+1% +$84.1K 0.42% 42
2025
Q3
$6.46M Sell
8,461
-203
-2% -$151K 0.34% 53
2025
Q2
$6.75M Buy
8,664
+349
+4% +$271K 0.4% 46
2025
Q1
$6.87M Sell
8,315
-17
-0.2% -$14.1K 0.45% 44
2024
Q4
$6.43M Sell
8,332
-3,586
-30% -$2.97M 0.42% 44
2024
Q3
$10.6M Buy
11,918
+3,349
+39% +$3.01M 0.6% 33
2024
Q2
$7.76M Sell
8,569
-148
-2% -$118K 0.58% 36
2024
Q1
$6.78M Sell
8,717
-1,727
-17% -$1.23M 0.53% 35
2023
Q4
$6.09M Buy
10,444
+1,110
+12% +$648K 0.44% 43
2023
Q3
$5.01M Buy
9,334
+427
+5% +$220K 0.42% 46
2023
Q2
$4.18M Buy
8,907
+512
+6% +$215K 0.36% 55
2023
Q1
$2.88M Buy
8,395
+1,235
+17% +$417K 0.27% 84
2022
Q4
$2.62M Sell
7,160
-4,999
-41% -$1.77M 0.27% 97
2022
Q3
$4M Buy
12,159
+2,304
+23% +$730K 0.23% 99
2022
Q2
$3.21M Sell
9,855
-428
-4% -$128K 0.18% 128
2022
Q1
$2.94M Buy
10,283
+5,881
+134% +$1.51M 0.14% 151
2021
Q4
$1.22M Buy
+4,402
New +$1.12M 0.12% 168
2021
Q2
$1.42M Buy
6,205
+2,123
+52% +$426K 0.15% 153
2021
Q1
$763K Buy
4,082
+211
+5% +$41.3K 0.1% 202
2020
Q4
$654K Sell
3,871
-1,060
-21% -$158K 0.1% 210
2020
Q3
$730K Sell
4,931
-124
-2% -$19.2K 0.12% 189
2020
Q2
$830K Buy
5,055
+80
+2% +$12.3K 0.15% 151
2020
Q1
$687K Buy
4,975
+128
+3% +$17.6K 0.16% 141
2019
Q4
$637K Sell
4,847
-528
-10% -$61.2K 0.1% 202
2019
Q3
$599K Buy
5,375
+971
+22% +$108K 0.12% 187
2019
Q2
$486K Sell
4,404
-864
-16% -$102K 0.06% 228
2019
Q1
$684K Sell
5,268
-102
-2% -$12.4K 0.15% 156
2018
Q4
$622K Buy
+5,370
New +$600K 0.17% 153

Other funds holding LLY

Western Wealth Management's LLY Position: Q1 2026 in Review

Western Wealth Management increased its Eli Lilly (LLY) stake by 55% in Q1 2026, buying an estimated $4.73M and bringing the position to 13,214 shares worth $12.2M. The position accounts for 0.46% of the portfolio, ranked #39.

Western Wealth Management first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Western Wealth Management held 13,214 shares of Eli Lilly worth $12.2M as of Q1 2026.
  • Western Wealth Management bought 4,665 Eli Lilly shares in Q1 2026, an estimated $4.73M.
  • Eli Lilly made up 0.46% of Western Wealth Management's portfolio in Q1 2026, its #39 holding.
  • Western Wealth Management first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.